Atilla Yilmaz

Atilla Yilmaz

Auto-generated profile, based on publicly available information

Atilla Yilmaz

Clinic of Internal Medicine I, Department of Cardiology, University Hospital Jena, Jena, Germany

Research Focus & Metrics

Academic Career Length

26Years (2001-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2004 in Atherosclerosis
Verified
Journal Article
Closed access
AYAtilla Yilmaz
Atilla Yilmaz
MLMarlene Lochno
Marlene Lochno
FTFriedemann Traeg
Friedemann Traeg
Iwona CichaIwona Cicha
Iwona Cicha
CRChristine Reiss
Christine Reiss
CGChristoph D Garlichs
Christoph D Garlichs

1 January 2004 in Atherosclerosis
Verified
Journal Article
Closed access
AYAtilla Yilmaz
Atilla Yilmaz
CRChristine Reiss
Christine Reiss
OTOmeima Tantawi
Omeima Tantawi
AWAlexander Weng
Alexander Weng
CSChristian Stumpf
Christian Stumpf
CGChristoph D. Garlichs
Christoph D. Garlichs

19 October 2009 in Clinical Science
Verified
Journal Article
Closed access
PDF file
AYAtilla Yilmaz
Atilla Yilmaz
TFTanja Fuchs
Tanja Fuchs
BDBarbara Dietel
Barbara Dietel
RARegina Altendorf
Regina Altendorf
Iwona CichaIwona Cicha
Iwona Cicha
RKRainer Kollmar
Rainer Kollmar
The role of DCs (dendritic cells) as potent mediators of inflammation has not been sufficiently investigated in stroke. Therefore, in the present study, circulating mDCPs (myeloid DC precursors), pDCPs (plasmacytoid DCPs) and tDCPs (total DCPs) were analysed by flow cytometry in (i) healthy controls (n=29), (ii) patients with ACI-S (asymptomatic cerebral infarction stenosis; n=46), (iii) patients with TIA (transient ischaemic attack; n=39), (iv) patients with AIS (acute ischaemic stroke; n=73), and (v) patients with AHS (acute haemorrhagic stroke; n=31). The NIHSS (National Institutes of Health Stroke Scale) and infarction size on a CT (computer tomography) scan were evaluated after stroke. In a patient subgroup, post-mortem immunohistochemical brain analyses were performed to detect mDCs (CD209), pDCs (CD123), T-cells (CD3) and HLA-DR. In AIS and AHS, the numbers of circulating mDCPs (P<0.005), pDCPs (P<0.005) and tDCPs (P<0.001) were significantly reduced. A significant inverse correlation was found between the NIHSS and circulating DCPs (P<0.02), as well as between hsCRP (high-sensitivity C-reactive protein) and circulating DCPs (P<0.001). Patients with large stroke sizes on a CT scan had significantly lower numbers of mDCPs (P=0.007), pDCPs (P=0.05) and tDCPs (P=0.01) than those with smaller stroke sizes. Follow-up analysis showed a significant recovery of circulating DCPs in the first few days after stroke. In the infarcted brain, a dense infiltration of mDCs co-localized with T-cells, single pDCs and high HLA-DR expression were observed. In conclusion, acute stroke leads to a decrease in circulating DCPs. Potentially, circulating DCPs are recruited from the blood into the infarcted brain and probably trigger cerebral immune reactions there.

15 January 2009 in Clinical Science
Verified
Journal Article
Closed access
AYAtilla Yilmaz
Atilla Yilmaz
TSTina Schaller
Tina Schaller
Iwona CichaIwona Cicha
Iwona Cicha
RARegina Altendorf
Regina Altendorf
CSChristian Stumpf
Christian Stumpf
CGChristoph D. Garlichs
Christoph D. Garlichs
DCs (dendritic cells) are present in atherosclerotic lesions leading to vascular inflammation, and the number of vascular DCs increases during atherosclerosis. Previously, we have shown that the levels of circulating DCPs (DC precursors) are reduced in acute coronary syndromes through vascular recruitment. In the present study, we have investigated whether DCP levels are also reduced in stable CAD (coronary artery disease). The levels of circulating mDCPs (myeloid DCPs), pDCPs (plasmacytoid DCPs) and tDCP (total DCPs) were investigated using flow cytometry in 290 patients with suspected stable CAD. A coronary angiogram was used to evaluate a CAD score for each patient as follows: (i) CAD excluded (n=57); (ii) early CAD (n=63); (iii) moderate CAD (n=85); and (iv) advanced CAD (n=85). Compared with controls, patients with advanced stable CAD had lower HDL (high-density lipoprotein)-cholesterol (P=0.03) and higher creatinine (P=0.003). In advanced CAD, a significant decrease in circulating mDCPs, pDCPs and tDCPs was observed (each P<0.001). A significant inverse correlation was observed between the CAD score and mDCPs, pDCPs or tDCPs (each P<0.001). Patients who required percutaneous coronary intervention or coronary artery bypass grafting had less circulating mDCPs, pDCPs and tDCPs than controls (each P<0.001). Multiple stepwise logistic regression analysis suggested mDCPs, pDCPs and tDCPs as independent predictors of CAD. In conclusion, we have shown that patients with stable CAD have significantly lower levels of circulating DCPs than healthy individuals. Their decrease appears to be an independent predictor of the presence of, and subsequent therapeutic procedure in, stable CAD.

12 January 2016 in European Journal of Clinical Investigation
Verified
Journal Article
Closed access
PDF file
AYAtilla Yilmaz
Atilla Yilmaz
JRJosi Ratka
Josi Ratka
IRIlonka Rohm
Ilonka Rohm
RPRudin Pistulli
Rudin Pistulli
BGBjorn Goebel
Bjorn Goebel
CJChristian Jung
Christian Jung

1 March 2010
Verified
Journal Article
Open access
AYAtilla Yilmaz
Atilla Yilmaz
BDBarbara Dietel
Barbara Dietel
Iwona CichaIwona Cicha
Iwona Cicha
KSKatja Schubert
Katja Schubert
RHRoland Hausmann
Roland Hausmann
CSChristian Stumpf
Christian Stumpf
Dendritic cells (DC) are crucial for T cell mediated immune responses. Recently, we observed a significant decrease in circulating myeloid DC precursors in patients with acute myocardial infarction (AMI). The aim of the present study was to investigate whether myeloid DC are present in infarcted myocardium. Myocardial specimens of 10 patients with AMI and 7 accident victims (controls) were collected after autopsy. In immunostainings the presence of DC (CD209(+), fascin(+)), T cells (CD3(+)), macrophages (CD68(+)), and HLA-DR expression was analyzed. Significantly higher numbers of CD209(+)-DC (97 vs. 44 cells/0.25 mm(2), p=0.03), fascin(+)-DC (54 vs. 8 cells/0.25 mm(2), p=0.02), T cells (27 vs. 6 cells/0.25 mm(2), p=0.02), and macrophages (44 vs. 6 cells/0.25 mm(2), p=0.01) associated with high HLA-DR expression were detected in infarcted myocardium. Frequent colocalizations of DC and T cells were observed. In occluded coronary arteries numerous DC, T cells, macrophages and high HLA-DR expression were found. We show that DC are present in infarcted myocardium after AMI. High HLA-DR expression and the colocalization with T cells suggest that they might trigger an immune response leading to further myocardial damage.